Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06906887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv4
  2. Notable Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jun 1, 2025 to Jun 17, 2025 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Jun 1, 2025 to Jun 17, 2025
    • Site details revised
  3. Minor Interventions: Chemotherapy (Drug), Conventional Radiation (Radiation), Induction Chemotherapy (modified FLOT or FOLFOX-6) (Drug), Pulsed Low-Dose-Rate… to Chemotherapy (Drug), Conventional Radiation (Radiation), Induction Chemotherapy (modified FLOT or modified FOLFOX-6) (Drug), Pulsed… Study description shortened, about 4 wordsv2 Show 1 more changeShow less
    • Study description shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.
Trial Details
NCT Number NCT06906887
Lead Sponsor Medical College of Wisconsin
Conditions Esophageal Cancer, Oesophageal Cancer, GastroEsophageal Cancer
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov